i reckon next price sensitive ann will be update on the stem cell CoH trials -due anytime, some thought on SScene by end of Jan.
it's been underway long enough, and hasn't been shut down by FDA, so can't be a dangerous failure. CoH are advertising for more patients to take part. Might have been a couple of dud results.
also expect an ann on T Cell therapy IND filing and maybe even commencement of T Cell clinical trial (PI) before court & USPTO sorted.
and the ann that we will never see coming but always lurks is a buyout
BLT Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held